XML 41 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Allocated Stock-Based Compensation Expense
The Company recorded stock-based compensation expense related to stock options and shares issued under the Company's 2017 Employee Stock Purchase Plan (2017 Plan) in the following expense categories of its accompanying consolidated statements of operations for the three and nine months ended September 30, 2020 and 2019:
Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Cost of product sales$25 $33 $113 $78 
Research and development334 90 922 617 
General and administrative2,267 2,312 6,822 6,857 
$2,626 $2,435 $7,857 $7,552 
Schedule of Stock Option Activity
The following table summarizes the activity related to stock option grants to employees and nonemployees for the nine months ended September 30, 2020:
 SharesWeighted
average
exercise price
per share
Weighted
average
remaining
contractual life
Outstanding at December 31, 20197,399,217 $9.81 6.37
Granted1,303,210 5.64 
Exercised(71,748)2.26 
Expired— —  
Forfeited(472,927)10.13
Outstanding at September 30, 20208,157,752 $9.19 6.12
Exercisable at September 30, 20205,384,480 $9.58 4.83
Vested and expected to vest at September 30, 20208,157,752 $9.19 6.12
Schedule of Fair Value Options using Black-Scholes Pricing Model
The grant date fair value of each stock option grant was estimated at the time of grant using the Black-Scholes option-pricing model using the following weighted average assumptions:
Nine Months Ended September 30,
20202019
Risk free interest rate0.71 %2.48 %
Expected term (in years)6.036.05
Expected volatility68.77 %67.03 %
Annual dividend yield0.00 %0.00 %
Fair value of common stock$5.64 $7.70 
The Company calculated the fair value of each option grant and the shares issued under the 2017 Plan on the respective dates of grant using the following weighted average assumptions:
Nine Months Ended September 30,
20202019
Risk free interest rate0.96 %2.32 %
Expected term (in years)0.50.5
Expected volatility84.55 %73.34 %
Annual dividend yield0.00 %0.00 %
Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes the activity related to RSUs granted to employees for the nine months ended September 30, 2020:
 Shares
Balance at December 31, 2019— 
Granted1,542,172 
Vested and settled— 
Expired/forfeited/canceled(42,716)
Balance at September 30, 20201,499,456 
Expected to vest at September 30, 20201,499,456